Canadian application, no grantCanada
Modulation of cytochrome p450 reductase activity
CA 2403235 A1 · Owner: Henderson, Colin J. · Inventors: Henderson, Colin J.; Wolf, C. Roland
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The use of a non-human transgenic animal having cells with a conditional deletion of cytochrome P450 reductase gene in product development, disposition or toxicity studies or, in rationalised product design or product discovery.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 13, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 13, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 13, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 13, 2002
GrantedNo grant recorded
Term endedSeptember 13, 2022
Patent numberCA 2403235 A1
Classification (IPC)C12Q1/68 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.